Market Overview:
The global bare-metal vascular stents market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in stent technology, and rising demand for minimally invasive procedures. Based on type, the global bare-metal vascular stents market is segmented into coronary stents and peripheral stents. The coronary segment is expected to account for the majority of the share in terms of revenue during the forecast period owing to high prevalence of coronary artery diseases (CAD) across the globe. Based on application, hospitals & cardiac centers are anticipated to hold a dominant position in terms of revenue during 2018–2030 due high adoption rates for these devices among patients suffering from CADs and other heart conditions.
Product Definition:
Bare-metal vascular stents are small, mesh-like tubes that are inserted into an artery to prop it open and improve blood flow. They are often used to treat coronary artery disease.
Coronary Stents:
A coronary stent is a device used to treat heart conditions such as blocked arteries. The most common symptom of which is chest pain. A coronary stent is placed in the artery, which helps to clear the blockage and restore blood flow through the affected artery. There are two types of coronary stents: drug-eluting and bare-metal (or direct).
Peripheral Stents:
Peripheral stents are used to treat aneurysms and help restore blood flow in the brain, peripheral arteries, and veins. The stent is placed in the damaged area of a blood vessel wall and helps promote healing. In some cases, it may be necessary to place a stent across larger vessels or multiple smaller ones depending on the site of aneurysm & severity of disease.
Application Insights:
Based on application, the market is segmented into hospitals & cardiac centers and ambulatory surgical centers. The hospitals & cardiac centers segment dominated the market in 2017 owing to increasing prevalence of heart diseases and rising number of coronary artery stents procedures. According to a study published by NCBI, it was estimated that around 5% to 10% of adults suffer from some form of cardiovascular disease in a given year which accounts for more than 400,000 deaths globally each year.
The ambulatory surgical center (ASC) segment is expected to grow at a lucrative rate during the forecast period due largely to growing awareness about preventative healthcare coupled with rising disposable income levels among people across various regions including North America and Europe.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large patient pool and well-established healthcare infrastructure. Moreover, increasing government funding for R&D activities pertaining to advanced coronary stents is also expected to drive growth during the forecast period. Europe accounted for over 25% of share in 2017 due to high product adoption rate and growing geriatric population prone to cardiac disorders.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing with developing economies such as India & China, expanding medical tourism industry, rising awareness about bare-metal stents among patients & physicians, availability of cost-effective treatment options etc. In addition, rapidly improving healthcare infrastructure coupled with increasing disposable income levels will further propel regional demand during the forecast years 8)). For instance; according High Street Vascular Care (HSC), Japan has more than 2000 BMSs implanted every year whereas Australia implants around 400 per year 9).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Rising geriatric population
- Growing demand for minimally invasive procedures
- Technological advancements in vascular stents
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Bare-metal Vascular Stents Market Research Report
By Type
Coronary Stents, Peripheral Stents, Others
By Application
Hospitals & Cardiac Centers, Ambulatory Surgical Centers
By Companies
Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), Medtronic, plc (Ireland), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), JOTEC GmbH (Germany)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Bare-metal Vascular Stents Market Report Segments:
The global Bare-metal Vascular Stents market is segmented on the basis of:
Types
Coronary Stents, Peripheral Stents, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Cardiac Centers, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic, plc (Ireland)
- Abbott Laboratories (U.S.)
- Boston Scientific Corporation (U.S.)
- BIOTRONIK SE & Co. KG (Germany)
- B. Braun Melsungen AG (Germany)
- Terumo Corporation (Japan)
- STENTYS SA (France)
- MicroPort Scientific Corporation (China)
- Meril Life Sciences Pvt. Ltd. (India)
- Vascular Concepts (India)
- Medtronic, plc (Ireland)
- C. R. Bard (U.S.)
- Endologix, Inc. (U.S.)
- Lombard Medical Technologies (U.K.)
- Translumina GmbH (Germany)
- JOTEC GmbH (Germany)
Highlights of The Bare-metal Vascular Stents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Coronary Stents
- Peripheral Stents
- Others
- By Application:
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bare-metal Vascular Stents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bare-metal vascular stents are metal devices that are inserted into the arteries to prop them open and prevent blood from clotting.
Some of the major players in the bare-metal vascular stents market are Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), Medtronic, plc (Ireland), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), JOTEC GmbH (Germany).
The bare-metal vascular stents market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bare-metal Vascular Stents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bare-metal Vascular Stents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bare-metal Vascular Stents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bare-metal Vascular Stents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bare-metal Vascular Stents Market Size & Forecast, 2020-2028
4.5.1 Bare-metal Vascular Stents Market Size and Y-o-Y Growth
4.5.2 Bare-metal Vascular Stents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Coronary Stents
5.2.2 Peripheral Stents
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals & Cardiac Centers
6.2.2 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bare-metal Vascular Stents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bare-metal Vascular Stents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Coronary Stents
9.6.2 Peripheral Stents
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals & Cardiac Centers
9.10.2 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Coronary Stents
10.6.2 Peripheral Stents
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals & Cardiac Centers
10.10.2 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Coronary Stents
11.6.2 Peripheral Stents
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals & Cardiac Centers
11.10.2 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Coronary Stents
12.6.2 Peripheral Stents
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals & Cardiac Centers
12.10.2 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Coronary Stents
13.6.2 Peripheral Stents
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals & Cardiac Centers
13.10.2 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bare-metal Vascular Stents Market: Competitive Dashboard
14.2 Global Bare-metal Vascular Stents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic, plc (Ireland)
14.3.2 Abbott Laboratories (U.S.)
14.3.3 Boston Scientific Corporation (U.S.)
14.3.4 BIOTRONIK SE & Co. KG (Germany)
14.3.5 B. Braun Melsungen AG (Germany)
14.3.6 Terumo Corporation (Japan)
14.3.7 STENTYS SA (France)
14.3.8 MicroPort Scientific Corporation (China)
14.3.9 Meril Life Sciences Pvt. Ltd. (India)
14.3.10 Vascular Concepts (India)
14.3.11 Medtronic, plc (Ireland)
14.3.12 C. R. Bard (U.S.)
14.3.13 Endologix, Inc. (U.S.)
14.3.14 Lombard Medical Technologies (U.K.)
14.3.15 Translumina GmbH (Germany)
14.3.16 JOTEC GmbH (Germany)
